Estrogen replacement therapy (ERT)ReferencesCitationsSperoff L, Fritz MA (2005). Menopause and the
perimenopausal transition. In Clinical Gynecologic
Endocrinology and Infertility, 7th ed., pp. 621–688. Philadelphia:
Lippincott Williams and Wilkins. Rapkin AJ, et al. (2002). The clinical nature and
formal diagnosis of premenstrual, postpartum, and perimenopausal affective
disorders. Current Psychiatry Reports, 4(6):
419–428. Bachmann GA, et al. (2007). Lowest effective
transdermal 17beta-estradiol dose for relief of hot flashes in postmenopausal
women. Obstetrics and Gynecology, 110(4):
771–779. American College of Obstetricians and Gynecologists
Women's Health Care Physicians (2004). Stroke. Obstetrics and
Gynecology, 104(4, Suppl): 97S–105S. American College of Obstetricians and Gynecologists
Women's Health Care Physicians (2004). Venous thromboembolic disease.
Obstetrics and Gynecology, 104(4, Suppl):
118S–127S. Scarabin PY, et al. (2003). Differential association
of oral and transdermal oestrogen-replacement therapy with venous
thromboembolism risk. Lancet, 362(9382):
428–432. Million Women Study Collaborators (2003). Breast
cancer and hormone-replacement therapy in the Million Women Study.
Lancet, 362(9382): 419–427. Women's Health Initiative Steering Committee (2004).
Effects of conjugated equine estrogen in postmenopausal women with
hysterectomy. JAMA, 291(14): 1701–1712. Beral V, et al. (2007). Ovarian cancer and hormone
replacement therapy in the Million Women Study. Lancet,
369(9574): 1703–1710. Espeland MA, et al. (2004). Conjugated equine
estrogens and global cognitive function in postmenopausal women: Women's Health
Initiative Memory Study. JAMA, 291(24):
2959–2968. Barr RG, et al. (2004). Prospective study of
postmenopausal hormone use and newly diagnosed asthma and chronic obstructive
pulmonary disease. Archives of Internal Medicine,
164(4): 379–386.
| |